Neurodegeneration in multiple sclerosis

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Multiple sclerosis (MS) is a complex CNS disease causing axonal loss and neurodegeneration.
• Current immunomodulatory therapies manage inflammatory relapses but do not halt progressive disease or cure MS.
• Axonal degeneration contributes significantly to irreversible neurological deficits in MS patients.

Purpose of the Study:

• To review current understanding of MS pathogenesis, focusing on mechanisms of neurodegeneration.
• To identify early signs of axonal dysfunction and factors contributing to chronic axonal loss.
• To highlight the need for neuroprotective and regenerative strategies for MS treatment.

Main Methods:

• Analysis of data from MS patients, post-mortem studies, and animal models of demyelination.
• Review of proposed MRI and molecular biomarkers for predicting neurodegeneration.
• Examination of early axonal dysfunction indicators like impaired mitochondrial trafficking and synaptic alterations.

Main Results:

• Chronic demyelination and inflammation in the CNS perpetuate axonal loss.
• Impaired remyelination hinders repair processes.
• Early axonal dysfunction includes mitochondrial, structural, and synaptic changes.

Conclusions:

• Understanding MS pathogenesis is crucial for developing neuroprotective therapies.
• Regenerative and neuroprotective strategies are essential for preserving axonal integrity.
• Early intervention is critical to rescue axonal function and mitigate CNS atrophy in MS.